INTRODUCTION
============

Infertility affects approximately 15%-20% of couples who attempt to have children. Reciprocal translocations are present in 0.9/1000 newborns, and the incidence in the infertile male population is 7-10 times higher than in fertile men ([@B1], [@B2]). Balanced translocation is the most common structural rearrangement in humans ([@B3]). Chromosomal translocations may cause the loss of genetic material at the breakpoints and could result in testicular failure ([@B4]). Individuals affected by such translocations are associated with reproductive problems such as infertility, recurrent pregnancy loss, and malformed offspring ([@B5]). These effects are related to the specific chromosomes and breakpoints involved in the translocation ([@B6], [@B7]). Some translocation breakpoints can disrupt the structure of an important gene, leading to male infertility ([@B8]).

The genetic counseling of male carriers of translocations remains challenging. Preimplantation genetic diagnosis (PGD) is a recommended part of such counseling for those with balanced translocation with normal or abnormal semen. In vitro fertilization accompanied by PGD increases the chance of their fathering a healthy child ([@B9]). In azoospermia patients, pregnancy success and fertility may be achieved via intracytoplasmic sperm injection, using spermatozoa obtained from testis by microdissection testicular sperm extraction ([@B10], [@B11]).

However, De Krom et al. ([@B12]) reported that clinical characteristics including spontaneous abortion do not differ between those couples who accept and those who decline PGD. A systematic review also showed a lack of sufficient evidence that PGD improves the live birth rate in couples with repeated miscarriage carrying a structural chromosome abnormality ([@B13]). In addition, the natural pregnancy success rates for couples in which the male carries a translocation ranges from 30% to 70% ([@B14]). This suggests that continuing attempts to conceive naturally are a viable option for successful pregnancy. Hence, the relationship between chromosome structure abnormality and clinical features warrants further studies.

There may be important genes associated with spermatogenesis on chromosome 2. For example, follicle-stimulating hormone receptor (FSHR) is located on chromosome 2p16.3, and is expressed in testicular tissue of idiopathic azoospermic patients with severe spermatogenic defects. Its differential expression may be associated with the degree of spermatogenesis ([@B15]). A study has also shown that genetic polymorphisms in the FSHR gene might increase the susceptibility to azoospermia in Iranian men ([@B16]). However, the FSHR polymorphisms at the studied sites were shown not to be associated with idiopathic male infertility or to influence FSH levels in both normal and infertile males in the Han-Chinese population ([@B17]). In addition, the SPAG16 gene (sperm-associated antigen 16), mapped on chromosome 2 at 2q34, has been reported to be associated with impaired sperm motility ([@B18]). The breakpoints of 2q25.1, q11.2, and q31 have also been shown to be related to impaired spermatogenesis ([@B19]).

The present study was established to explore the clinical features and translocation breakpoints in carriers of reciprocal chromosomal translocations involving chromosome 2. This study also highlights the importance of genetic counseling for infertile patients.

MATERIALS AND METHODS
=====================

Study subjects
--------------

Between July 2010 and December 2015, we recruited 82 male carriers of translocations experiencing infertility, or receiving counseling, from the outpatient\'s department at the Centre for Reproductive Medicine, the First Hospital of Jilin University, Changchun, China. All patients underwent a thorough physical examination and semen analysis, and were required to complete a detailed questionnaire pertaining to their smoking habits, marital status, medical history, and working conditions. The study protocol was approved by the Ethics Committee of the First Hospital of Jilin University, and written informed consent was obtained from all participants.

Semen analysis
--------------

Semen analysis was performed according to the procedures recommended by the World Health Organization guideline. If no sperm was found, sperm was analyzed by sedimentation of semen samples through centrifugation. Patients with oligozoospermia were diagnosed as a sperm cell count \<15×10^6^/mL in their last 3 semen samples (taken at intervals of 1-3 weeks). Azoospermia and oligozoospermia were defined as previously described ([@B8]). All analyzes were performed at the same laboratory, and all data were accessed from medical records.

Cytogenetic analysis
--------------------

Cytogenetic analysis was carried out on all patients. Peripheral blood (0.5mL) was collected in sterile tubes containing 30U/mL heparin. Lymphocytes were then cultured in appropriate culture medium (Yishengjun; Guangzhou Baidi Biotech, Guangzhou, China) for 72h, and subsequently treated with colcemid for 1h. G-banding of meta-phase chromosomes and karyotype analysis were performed using previously described methods ([@B20]). Twenty metaphases were counted and 6 karyotypes were analyzed for per patient. The karyotype nomenclature was described in accordance of ISCN 2009. The resolution level of the chromosome analysis was 400-550 band levels.

Analysis of the identified translocation breakpoints
----------------------------------------------------

A search for the translocations identified in chromosome 2 from infertile males was performed using PubMed. The keywords were "chromosome/translocation/sperm" and "chromosome/translocation/abortion" for Pubmed search. The criteria were that the patients included reciprocal chromosomal translocations involving chromosome 2 in reported papers. The relationships of translocation breakpoints with male infertility and recurrent pregnancy loss were analyzed. Such searches were performed for a total of 46 carriers of chromosomal 2 translocations. This study included the cases of reciprocal chromosomal translocations involving chromosome 2 in reported papers and excluded the cases without breakpoints involving chromosome 2.

RESULTS
=======

A total of 82 translocation carriers were detected in this study. Of these, nine (11%) were carriers of a chromosome 2 translocation. Karyotype results from these nine patients are summarized in [Table-1](#t1){ref-type="table"}. Four cases had oligozoospermia or infertility (pre-gestational infertility), while five cases had normal semen. Of these latter five cases, it was evident that their partners were able to conceive, but had a tendency to miscarry (gestational infertility): one case had experienced recurrent spontaneous abortions, one case had experienced two stillbirths, and one case had experienced biochemical pregnancy on three occasions, while two cases produced a phenotypically normal child.

###### Karyotypes of chromosome 2 translocation carriers and their clinical features.

  ------------------------------------------------------------------------------------------------------------------------------------------
  Infertility causes            Clinical findings                                                                 Karyotype
  ----------------------------- --------------------------------------------------------------------------------- --------------------------
  Pre-gestational infertility   Oligozoospermia or infertility                                                    46,XY,t(1;2)(q21;p23)\
                                                                                                                  46,XY,t(1;2)(q21;q37)\
                                                                                                                  46,XY,t(2;13)(q10;q10)\
                                                                                                                  46,XY,t(2;15)(p11.2;q15)

  Gestational infertility       Normal sperm density; a history of miscarriage, stillbirth, or normal fertility   46,XY,t(2;6)(q21;p21)\
                                                                                                                  46,XY,t(2;11)(q33;q23)\
                                                                                                                  46,XY,t(2;11)(q35;q13)\
                                                                                                                  46,XY,t(2;14)(q31;q24)\
                                                                                                                  46,XY,t(2;16)(p23;q13)
  ------------------------------------------------------------------------------------------------------------------------------------------

An analysis of the literature was also performed, from which karyotype results, clinical manifestations, and the breakpoints on chromosome 2 were collected, as shown in [Table-2](#t2){ref-type="table"}. Breakpoints at 2p13 and 2q31 were observed in six patients each, and were the most common. Breakpoints at q10 and q11.2 were related to pre-gestational infertility, while breakpoints at 2p23, 2p13, 2p11.2, 2q31, and 2q37 were connected to both pre-gestational and gestational infertility. Other breakpoints were associated with gestational infertility. It is noteworthy that two carriers of a translocation at 2q33 produced normal children, as did one carrier of a translocation at 2q35 ([Table-3](#t3){ref-type="table"}).

###### Breakpoints in chromosome 2 translocation carriers and clinical features.

  Case   Karyotype   Breakpoints      Clinical findings                             Reference
  ------ ----------- ---------------- --------------------------------------------- ------------------------------------------
  1      t(1;2)      1p22;2q31        2 miscarriages                                Dong et al., 2014 ([@B31])
  2      t(1;2)      1q21;2p23        Oligozoospermia                               The present study
  3      t(1;2)      1q21;2q37        Oligozoospermia                               The present study
  4      t(1;2)      1q21;2q37        Oligozoospermia                               Li et al., 2012 ([@B23])
  5      t(1;2)      1q32;2q36        Abortion                                      Templado et al., 1990 ([@B32])
  6      t(1;2)      1q32.1;2q11.2    Oligozoospermia                               Vozdova et al., 2013 ([@B9])
  7      t(1;2)      1q42;2q37        2 fetal malformations                         Zhang et al., 2006 ([@B33])
  8      t(1;2)      1q42;2q33        Miscarriage                                   Stasiewicz-Jarocka et al., 2000 ([@B34])
  9      t(2;3)      2p13;3q27        Recurrent pregnancy loss                      Ocak et al., 2013 ([@B35])
  10     t(2;3)      2q21; 3p21       Recurrent spontaneous abortion                Tunç et al., 2016 ([@B26])
  11     t(2;3)      2q24;3p26)       Normal semen                                  Martin, 1994 ([@B36])
  12     t(2;4)      2p21;4p14        Recurrent abortion                            Portnoï et al., 1988 ([@B37])
  13     t(2;4)      2q31;4q31        Stillbirth                                    Li et al., 2012 ([@B23])
  14     t(2;4)      2q31;4q31        2 stillbirths                                 Dong et al., 2014 ([@B31])
  15     t(2;5)      2p21;5p15        Recurrent spontaneous abortion                Gada Saxena et al., 2012 ([@B25])
  16     t(2;5)      2p13;5p15        Recurrent fetal wastage                       Fryns et al., 1998 ([@B38])
  17     t(2;5)      2p11;5q15        Abortion                                      Templado et al., 1988 ([@B39])
  18     t(2;5)      2p11;5q31        Recurrent abortion                            Portnoï et al., 1988 ([@B37])
  19     t(2;5)      2q12;5q35.3      Spontaneous miscarriage                       Kochhar et al., 2013 ([@B40])
  20     t(2;6)      2p13;6p21.3      Recurrent abortion                            Al-Hussain et al., 2000 ([@B41])
  21     t(2;6)      2p12;6q24        Two earlier miscarriages                      Lim et al., 2003 ([@B42])
  22     t(2;6)      2q21;6p21        3 first-trimester abortions                   The present study
  23     t(2;6)      2q34;6p24        Recurrent spontaneous abortion                Gada Saxena et al., 2012 ([@B25])
  24     t(2;7)      2p23;7p22        Recurrent fetal wastage                       Fryns et al., 1998 ([@B38])
  25     t(2;7)      2p13;7q34        Normal semen, IVF/PGD ET, twins 46,XX         Vozdova et al., 2013 ([@B9])
  26     t(2;7)      2p13;7q32        Primary infertility, abnormal semen           Vozdova et al., 2013 ([@B9])
  27     t(2;7)      2q31;7q34        Abnormal semen                                Vozdova et al., 2013 ([@B9])
  28     t(2;7)      2p11.2;7q22.1    2 miscarriages                                Wiland et al., 2008 ([@B3])
  29     t(2;7)      2q37.3;7q34)     3 miscarriages                                Ahn et al., 2003 ([@B43])
  30     t(2;8)      2p13;8q13        Multiple spontaneous abortions                Castle et al., 1988 ([@B44])
  31     t(2;8)      2p22;8p23.1      Spontaneous abortions                         Kyu Lim et al., 2004 ([@B45])
  32     t(2;8)      2q35;8q11.2      Spontaneous abortions                         Kyu Lim et al., 2004 ([@B45])
  33     t(2;8)      2q37;8q22        3 abortions                                   Campana et al., 1986 ([@B46])
  34     t(2;9)      2q21;9p22        Abortion                                      Martin et al., 1990 ([@B47])
  35     t(2;9)      2q37.3;9q12      Normal semen, increased risk of miscarriage   Dul et al., 2012 ([@B48])
  36     t(2;10)     2q33;10q24       Produced a child, 46,XX                       Faed et al., 1982 ([@B49])
  37     t(2;11)     2p14;11q21       Repeated abortion                             Ananthapur et al., 2014 ([@B5])
  38     t(2;11)     2q24;11q32       Recurrent abortion                            Al-Hussain et al., 2000 ([@B41])
  39     t(2;11)     2q33;11q23       Produced a child, 46,XX                       The present study
  40     t(2;11)     2q35;11q13       Produced a child, 46,XX,t(2;11)               The present study
  41     t(2;12)     2q31;12q24       3 first-trimester abortions                   Niroumanesh et al., 2011 ([@B50])
  42     t(2;13)     2q35;13q32       Repeated miscarriage                          Goddijn et al., 2004 ([@B51])
  43     t(2;13)     2q10;13q10       Oligozoospermia                               The present study
  44     t(2; 14)    2p23.1;14q31     Abortion                                      Rousseaux et al., 1995 ([@B52])
  45     t(2;14)     2q12;14q32.33    Recurrent spontaneous abortion                Manvelyan et al., 2007 ([@B27])
  46     t(2;14)     2q31;14q24       2 stillbirths                                 The present study
  47     t(2;14)     2q37.1;14q31.2   Fetal malformations                           de la Fuente et al., 1988 ([@B53])
  48     t(2;15)     2p11.2;15q15     Infertility                                   The present study
  49     t(2;15)     2q21;15p12       Recurrent fetal wastage                       Fryns et al., 1998 ([@B38])
  50     t(2;16)     2p23;16q13       Recurrent spontaneous abortion                The present study
  51     t(2;17)     2q35;17p13       Abortion                                      Jenderny, 1992 ([@B54])
  52     t(2;17)     2q37.2; 17q25    Recurrent spontaneous abortion                Bruyere et al., 2003 ([@B55])
  53     t(2;18)     2p21;18q11.2     5 miscarriages                                Estop et al., 1995 ([@B56])
  54     t(2;20)     2p16;20p12       Recurrent abortion                            Sachs et al., 1985 ([@B57])
  55     t(2;20)     2p24.1;20q13.1   Recurrent abortion                            Trappe et al., 2002 ([@B58])

###### Incidence of breakpoints on chromosome 2.

  Breakpoints   Number of patients with pre-gestational infertility   Number of patients with gestational infertility   Reproductive outcomes
  ------------- ----------------------------------------------------- ------------------------------------------------- --------------------------------------------------
  p24.1                                                               1                                                 
  p23.1                                                               1                                                 
  p23           1                                                     2                                                 
  p22                                                                 1                                                 
  p21                                                                 3                                                 
  p16                                                                 1                                                 
  p14                                                                 1                                                 
  p13           1                                                     4                                                 1 case of IVF/PGD ET, twins 46,XX
  p12                                                                 1                                                 
  p11.2         1                                                     1                                                 
  p11                                                                 2                                                 
  q10           1                                                                                                       
  q11.2         1                                                                                                       
  q12                                                                 2                                                 
  q21                                                                 4                                                 
  q24                                                                 2                                                 
  q31           1                                                     5                                                 
  q33                                                                 1                                                 2 cases of natural pregnancy, birth 46,XX
  q34                                                                 1                                                 
  q35                                                                 3                                                 1 case of natural pregnancy, birth 46,XX,t(2;11)
  q36                                                                 1                                                 
  q37           2                                                     2                                                 
  q37.1                                                               1                                                 
  q37.2                                                               1                                                 
  q37.3                                                               2                                                 
  p24.1                                                               1                                                 

DISCUSSION
==========

Karyotype analysis is able to detect chromosomal translocations or deletions, which sometimes have very detrimental effects on gene structure, and remains a powerful and cheap method to use ([@B21]). This technology thus provides valuable information for the genetic counseling of infertile males ([@B22]). Previous studies have reported that infertile men have an 8-10-fold higher prevalence of chromosomal abnormalities than fertile men ([@B23]). Chromosomal translocation alters the complex and vital process of spermatogenesis, and leads to recurrent pregnancy loss ([@B24]). In particular, chromosome 2 translocation has often been associated with male infertility and recurrent miscarriage ([@B9], [@B25], [@B26]). In the present study, nine of our cases were identified as carriers of chromosome 2 translocations, and 55 cases of chromosome 2 translocation from the literature were also reviewed.

Generally, male infertility can be broadly divided into two types of reproductive failure: pre-gestational and gestational infertility ([@B23]). In this study, the breakpoints that we identified on chromosome 2 were found to be associated with pre-gestational or gestational infertility. Four cases were associated with pre-gestational infertility and five cases were related to gestational infertility. Kim et al. ([@B19]) reported that the breakpoints at 2p25.1, 2q11.2, and 2q31 could interfere with spermatogenesis, and that the breakpoint at 2p13 was related to recurrent abortion. In addition, Manvelyan et al. ([@B27]) reported that the breakpoint at 2q12 in male carriers was associated with repeated abortion. To study the relationship of these breakpoints on chromosome 2 with male infertility, we analyzed recent published literature and revealed clinical features in carriers of chromosome 2 translocations. The karyotype results and clinical findings at chromosome 2 are summarized in [Table-2](#t2){ref-type="table"}. Clinical features associated with the breakpoints at 2p13, 2q11.2, and 2q12 were consistent with the above two reports ([@B19], [@B27]).

[Table-3](#t3){ref-type="table"} also shows that 2p23, 2p13, 2p11.2, 2q31, and 2q37 were connected to both pre-gestational and gestational infertility. These cases indicated that these breakpoints are not responsible for pre-gestational infertility, so another breakpoint of translocation must be the cause in these individuals. Similarly, the APOB gene is located on chromosome 2p24.1, and the APOB gene signal peptide deletion polymorphism was reported not to be associated with infertility in Indian men ([@B28]). Furthermore, FSHR, mapped on chromosome 2 at 2p16, was shown not to be correlated with sperm count in infertile males ([@B29]).

Besides the breakpoints at q10 and q11.2, other breakpoints were identified as being associated with gestational infertility. For those affected by these breakpoints, natural conception is possible and they have the potential to bear normal children. For example, Ikuma et al. ([@B30]) reported that the live birth rate with natural conception for translocation carriers was 37%-63% in the first trial and 65%-83% cumulatively. However, natural conception is still a greater risk, since the number of chromosomal unbalanced gametes is large, leading to repetitive pregnancy loss, which may have repercussions on the fertility of the translocation carrier. For these carriers, informed choice should be performed. In addition, the breakpoints at 2p13 and 2q31 were found to be the most common, and were associated with gestational infertility.

CONCLUSIONS
===========

In the present study, 55 carriers of chromo-some 2 translocations were reviewed. The breakpoints at 2p13 and 2q31 were the most common, and were associated with gestational infertility. All breakpoints at chromosome 2 were correlated with gestational infertility. Carriers of chromosome 2 translocations should therefore be counselled to attempt natural conception and to use the different technologies available via assisted reproductive technology, such as PGD.
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PGD

:   =Preimplantation genetic diagnosis

FSH

:   =Follicle-stimulating hormone

FSHR

:   =Follicle-stimulating hormone receptor

SPAG16 gene

:   =Sperm-associated antigen 16 gene

APOB gene

:   =Apolipoprotein B gene
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